These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35147657)

  • 21. Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
    Iro MA; Buckland M
    EBioMedicine; 2023 Dec; 98():104852. PubMed ID: 38251467
    [No Abstract]   [Full Text] [Related]  

  • 22. Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
    Ziegler L; Klemis V; Schmidt T; Schneitler S; Baum C; Neumann J; Becker SL; Gärtner BC; Sester U; Sester M
    EBioMedicine; 2023 Dec; 98():104853. PubMed ID: 38251468
    [No Abstract]   [Full Text] [Related]  

  • 23. Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(12):e48. PubMed ID: 34525292
    [No Abstract]   [Full Text] [Related]  

  • 24. Developing new COVID-19 vaccine against the variants is urgently needed rather than boosters: A longitudinal cohort study.
    Xu QY; Zheng XQ; Jia ZJ; Wu MJ; Liu YY; Liu LL; Lin LR; Yang TC
    J Infect; 2023 Feb; 86(2):e55-e57. PubMed ID: 36108784
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID vaccine boosters: the most important questions.
    Callaway E
    Nature; 2021 Aug; 596(7871):178-180. PubMed ID: 34354274
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
    Abu-Raddad LJ; Chemaitelly H; Bertollini R;
    N Engl J Med; 2022 Mar; 386(11):1091-1093. PubMed ID: 35081294
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 boosters: If everyone is at risk, no one is at risk.
    The Lancet Microbe
    Lancet Microbe; 2023 Oct; 4(10):e757. PubMed ID: 37748495
    [No Abstract]   [Full Text] [Related]  

  • 29. In brief: Booster doses of mRNA-based COVID-19 vaccines for all adults.
    Med Lett Drugs Ther; 2021 Dec; 63(1640):201-202. PubMed ID: 35100238
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
    Abu-Raddad LJ; Chemaitelly H; Bertollini R;
    N Engl J Med; 2022 Feb; 386(8):799-800. PubMed ID: 35045222
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 vaccine breakthrough infections.
    Gupta RK; Topol EJ
    Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
    Rubin R
    JAMA; 2022 Aug; 328(5):412-414. PubMed ID: 35802386
    [No Abstract]   [Full Text] [Related]  

  • 34. If the NHS falls short on boosters, it won't be for want of trying.
    Hopson C
    BMJ; 2021 Dec; 375():n3106. PubMed ID: 34916209
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
    Natarajan K; Prasad N; Dascomb K; Irving SA; Yang DH; Gaglani M; Klein NP; DeSilva MB; Ong TC; Grannis SJ; Stenehjem E; Link-Gelles R; Rowley EA; Naleway AL; Han J; Raiyani C; Benitez GV; Rao S; Lewis N; Fadel WF; Grisel N; Griggs EP; Dunne MM; Stockwell MS; Mamawala M; McEvoy C; Barron MA; Goddard K; Valvi NR; Arndorfer J; Patel P; Mitchell PK; Smith M; Kharbanda AB; Fireman B; Embi PJ; Dickerson M; Davis JM; Zerbo O; Dalton AF; Wondimu MH; Azziz-Baumgartner E; Bozio CH; Reynolds S; Ferdinands J; Williams J; Schrag SJ; Verani JR; Ball S; Thompson MG; Dixon BE
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):495-502. PubMed ID: 35358170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omicron likely to weaken COVID vaccine protection.
    Callaway E
    Nature; 2021 Dec; 600(7889):367-368. PubMed ID: 34880488
    [No Abstract]   [Full Text] [Related]  

  • 37. What's the evidence for COVID-19 booster shots?
    Vogel L; Duong D
    CMAJ; 2021 Sep; 193(35):E1400-E1401. PubMed ID: 34493570
    [No Abstract]   [Full Text] [Related]  

  • 38. Audio Interview: A New Round of Rising Covid-19 Numbers.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Sep; 385(10):e41. PubMed ID: 34469653
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective.
    Priyanka ; Choudhary OP; Singh I
    Hum Vaccin Immunother; 2022 Dec; 18(1):2020572. PubMed ID: 35026127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Vaccine Roundup.
    Am J Nurs; 2021 Nov; 121(11):16. PubMed ID: 34673683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.